Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schjetne, K. W.
Right arrow Articles by Bogen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schjetne, K. W.
Right arrow Articles by Bogen, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 14, No. 12, pp. 1423-1430, December 2002
© 2002 Japanese Society for Immunology

A mouse C{kappa}-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation

Karoline W. Schjetne1, Keith M. Thompson1, Tanja Aarvak1, Burkhard Fleckenstein1, Ludvig M. Sollid1 and Bjarne Bogen1

1 Institute of Immunology, University of Oslo, Rikshospitalet, 0027 Oslo, Norway

Correspondence to: K. W. Schjetne; E-mail: k.w.schjetne{at}labmed.uio.no or B.Bogen; E-mail: b.bogen{at}labmed.uio.no
Transmitting editor: D. R. Littman

In vaccine development, a major objective is to induce strong, specific T cell responses. This might be obtained by targeting antigen to cell surface molecules that efficiently channel the antigen into endocytic compartments for loading of MHC molecules. Antibodies have been used to deliver antigen; however, it is important to define optimal targets on antigen-presenting cells (APC) for efficient delivery. For this purpose, we have established a T cell readout that can be used to screen large numbers of different mAb for their ability to load MHC class II molecules. The novel human CD4+ T cell clone is specific for mouse Ig C{kappa} (40–48) and restricted by HLA-DR4 (DRA1,B1*0401). DR4 apparently presents both mouse and human C{kappa} 40–48, but there is no cross-reaction at the T cell level. B cells from DR4 transgenic mice spontaneously process and present the mouse C{kappa} peptide. The mouse C{kappa}-specific T cell readout was used to demonstrate that mouse mAb specific for human dendritic cell (DC)-specific ICAM-grabbing non-integrin (DC-SIGN), a novel DC-specific molecule, were 10- to 1000-fold more potent at inducing {kappa}-specific human CD4+ T cell proliferation compared to control mAb. Consistent with this finding, DC-SIGN-specific mAb were rapidly internalized upon binding and found in intracellular vesicles. These results strongly argue that DC-SIGN-specific mAb are channeled into the MHC class II presentation pathway. Thus, DC-SIGN could be an efficient target for antibody-mediated delivery of T cell epitopes in vaccine development.

Keywords: antigen presentation, CD4+ T cells, dendritic cells, vaccine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Flobakk, I. B. Rasmussen, E. Lunde, T. Frigstad, G. Berntzen, T. E. Michaelsen, B. Bogen, and I. Sandlie
Processing of an Antigenic Sequence from IgG Constant Domains for Presentation by MHC Class II
J. Immunol., November 15, 2008; 181(10): 7062 - 7072.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Tunheim, K. W. Schjetne, I. B. Rasmussen, L. M. Sollid, I. Sandlie, and B. Bogen
Recombinant antibodies for delivery of antigen: a single loop between {beta}-strands in the constant region can accommodate long, complex and tandem T cell epitopes
Int. Immunol., March 1, 2008; 20(3): 295 - 306.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Serrano-Gomez, R. T. Martinez-Nunez, E. Sierra-Filardi, N. Izquierdo, M. Colmenares, J. Pla, L. Rivas, J. Martinez-Picado, J. Jimenez-Barbero, J. L. Alonso-Lebrero, et al.
AM3 Modulates Dendritic Cell Pathogen Recognition Capabilities by Targeting DC-SIGN
Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2313 - 2323.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Dominguez-Soto, L. Aragoneses-Fenoll, E. Martin-Gayo, L. Martinez-Prats, M. Colmenares, M. Naranjo-Gomez, F. E. Borras, P. Munoz, M. Zubiaur, M. L. Toribio, et al.
The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells
Blood, June 15, 2007; 109(12): 5337 - 5345.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. W. Schjetne, A. B. Fredriksen, and B. Bogen
Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors
J. Immunol., April 1, 2007; 178(7): 4169 - 4176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Mansour, E. Latz, and S. M. Levitz
Cryptococcus neoformans Glycoantigens Are Captured by Multiple Lectin Receptors and Presented by Dendritic Cells.
J. Immunol., March 1, 2006; 176(5): 3053 - 3061.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Dominguez-Soto, A. Puig-Kroger, M. A. Vega, and A. L. Corbi
PU.1 Regulates the Tissue-specific Expression of Dendritic Cell-specific Intercellular Adhesion Molecule (ICAM)-3-grabbing Nonintegrin
J. Biol. Chem., September 30, 2005; 280(39): 33123 - 33131.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
I. Mende, P. Hoffmann, A. Wolf, R. Lutterbuse, E. Kopp, P. A. Baeuerle, A. de Baey, and P. Kufer
Highly efficient antigen targeting to M-DC8+ dendritic cells via Fc{gamma}RIII/CD16-specific antibody conjugates
Int. Immunol., May 1, 2005; 17(5): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. A. Snyder, J. Ford, P. Torabi-Parizi, J. A. Arthos, P. Schuck, M. Colonna, and P. D. Sun
Characterization of DC-SIGN/R Interaction with Human Immunodeficiency Virus Type 1 gp120 and ICAM Molecules Favors the Receptor's Role as an Antigen-Capturing Rather than an Adhesion Receptor
J. Virol., April 15, 2005; 79(8): 4589 - 4598.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Tunheim, K. W. Schjetne, A. B. Fredriksen, I. Sandlie, and B. Bogen
Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes
J. Leukoc. Biol., March 1, 2005; 77(3): 303 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Tobar, P. A. Gonzalez, and A. M. Kalergis
Salmonella Escape from Antigen Presentation Can Be Overcome by Targeting Bacteria to Fc{gamma} Receptors on Dendritic Cells
J. Immunol., September 15, 2004; 173(6): 4058 - 4065.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. A. Ruffini, A. Biragyn, M. Coscia, L. K. Harvey, S.-C. Cha, B. Bogen, and L. W. Kwak
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis
J. Leukoc. Biol., July 1, 2004; 76(1): 77 - 85.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.